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mortality and morbidity. Percutaneous closure is growing rapidly,
principally because of the patient’s, family’s, and pediatric cardiolo-
gist’s desire for a less invasive procedure. Considering the increase in
the number of procedures, a long-term follow-up is necessary to
evaluate the safety of mechanical occluders at long term. Our case
report described a complication that occurred 13 months after the
percutaneous procedure. The literature includes other authors report-
ing delayed heart perforation by the occluder device5; hence this
patient’s need for long-term echocardiographic follow-up to made an
early diagnosis of device failure and prevent emergency surgical
intervention. Finally, we conclude that patients should be informed
of the actual early and long-term results of surgical repair and
percutaneous approach to allow an informed decision.
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Complicated acute type B aortic dissection with
involvement of an aberrant right subclavian artery
and rupture of a thoracoabdominal aortic aneurysm,
Crawford type I: Successful emergency
endovascular treatment
Victor X. Mosquera, MD,a Milagros Marini, MD, PhD,b Fernando Rodríguez, MD,a
Ignacio Cao, MD,b and Alberto Juffé, MD, PhD,a A Coruña, Spain
Although an aberrant right subclavian artery (ARSA) isthe most common abnormality of aortic arch develop-ment, it is an unusual entity to encounter associated withthoracic aortic dissection. We report the successful en-
dovascular treatment of this association in a critically ill patient.
Clinical Summary
An 80-year-old man was referred
to our institution with the diag-
nosis of an acute aortic Stanford
type B dissection (Figure 1, A). The computed tomographic scan
images also showed a thoracoabdominal aortic aneurysm extend-
ing from an ARSA (Figure 1, B) to the esophageal hiatus (Craw-
ford type I).
Because of persistent back pain despite correct intravenous
treatment, a new computed tomographic scan was repeated 8 hours
later, revealing progression of the aortic dissection and the appear-
ance of a left-sided hemothorax. Blood analysis also showed a fall
of 10 points in the hematocrit value.
Because of the patient’s critical status and high surgical risk,
emergency endovascular treatment was indicated. Notwithstand-
ing, the procedure was technically demanding, because the en-
dograft had to be deployed while avoiding occlusion of the ARSA.
However, the diameter of the aortic aneurysm distal to the origin
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Figure 2. The removed Amplatzer device.
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of the ARSA was greater than 46 mm, which is the maximum
diameter amenable for the standard Medtronic Valiant thoracic
endograft (Medtronic, Inc, Santa Rosa, Calif). Therefore, the de-
ployment of the endoprosthesis was adjusted to the origin of the
ARSA, where the thoracic aneurysm had a neck of 42 mm. A
Valiant endograft, 160 mm in length and 46 mm in diameter, was
deployed at the level of ARSA origin, so that its floppy FreeFlo
straight portion (Figure 2, A), which is fenestrated, allowed blood
flow through the artery. In this way, the flow through the aberrant
artery was preserved (control computed tomographic scans, Figure
2, A and B).
There were no significant variations of invasive radial pressure
(10 mm Hg) between the two arms. The patient was discharged
from the hospital 6 days later.
Discussion
Aberrant subclavian artery, also called arteria lusoria, was first
described by Bayford in 1794. It is the most common form of
aortic arch anomaly and has a reported incidence of 0.5% to 2%.
It results from regression of the right fourth aortic arch between the
carotid and subclavian arteries.1
The association of aortic dissection and ARSA is rarely encoun-
tered; however, it has very important implications in treatment, either
surgical or endovascular. A number of surgical techniques have
been proposed for treatment of this pathologic condition. These
include transposition or bypass of the distal portion of the
aberrant artery into the adjacent carotid artery, resection of the
origin of the aneurysm from the descending thoracic aorta, and
repair of the aortic dissection/aneurysm with the elephant trunk
technique.2 The use of partial or total cardiopulmonary bypass,
hypothermia, and circulatory arrest is normally necessary. Nev-
ertheless, endovascular therapy has revolutionized this surgery.
Complex open surgical procedures may be replaced by endo-
vascular treatment, which is associated with a lower perioper-
ative morbidity and mortality.3
In this case, the very high surgical risk of the patient led us to
choose an endovascular treatment. We decided to use the Valiant
system, which is a third-generation endoprosthesis designed spe-
cifically for the exclusion of thoracic aortic disease.4 Its floppy
FreeFlo straight portion allowed us to deploy the endograft without
Figure 1. Contrast-enhanced slides of computed tomographic im-
age. Axial section of the thoracoabdominal aneurysm. A, Aortic
type B dissection (white arrow) with the false lumen (posterior)
compressing the true lumen (anterior). B, Origin of the ARSA
(black arrow).
Figure 2. Contrast-enhanced slide of computed tomographic im-
age. A, Coronal reconstruction of the distal aortic arch and
thoracic aorta. The floppy FreeFlo straight portion (white dashed
arrow) of the endograft preserved the patency of the ARSA (solid
white arrow). The false lumen of the aneurysm was completely
collapsed (dotted white arrow). B, Three-dimensional reconstruc-
tion of the aortic arch and origin of the supra-aortic vessels. Right
common carotid artery (white dotted arrow), left common carotid
artery (white dashed arrow), left subclavian artery (white arrow),
and aberrant subclavian artery (black arrow).
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occluding the ARSA and, therefore, without compromising either
the right arm blood supply or the right vertebral artery flow.
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Giant congenital left main coronary artery fistula to
the superior vena cava in an adult patient with
coronary artery disease
Ilias A. Kouerinis, MD, PhD,a Martha Deligianni, MD,b Vassilios Maniatis, MD, PhD,b
Ilias Elefteriadis, MD,b Antonios Kourtesis, MD,a and Nikolaos Michalopoulos, MD,b
Athens, Greece
Supplemental material is
available online.
It is well established that coronary artery fistulae (CAFs) cancause dyspnea, fatigue, angina (7%), and infarction (3%) asa result of the coronary steal phenomenon.1 Nevertheless,there are few reports in which a CAF was associated with
coronary artery disease (CAD), and even fewer studies have ex-
amined the consequences of this association on coronary hemody-
namics and myocardial blood flow.2,3
We present the surgical treatment of a giant left main coronary
artery (LMCA) fistula draining into the superior vena cava and
coexistent CAD, and we investigate the contribution of the coro-
nary steal syndrome to this patient’s symptoms.
Clinical Summary
A 62-year-old man was referred to our department with the diag-
nosis of an LMCA fistula and double-vessel disease (left anterior
descending coronary artery, 85%; circumflex artery, 80%; Figures
1, E1, and E2). Oxymetry had shown an increased oxygen satu-
ration of 84% at the lower segment of the superior vena cava with
high right ventricular filling pres-
sures, and the Qp/Qs ratio was
calculated at 1.4/1.
Intraoperatively, after the open-
ing of the pericardium, the fistula
was easily identified (Figure 2), and cardiopulmonary bypass was
initiated. After clamping the aorta, we provided retrograde cardio-
plegia to maintain arrest because significant shunt was noticed
during the antegrade distribution. This problem was subsequently
solved with digital pressure on the fistula, which was finally ligated
3 cm distally to the LMCA. We considered that it was too dan-
gerous to attempt to ligate it more proximally to the LMCA
because extreme calcification was palpated there. The check for
step-up in oxygen saturation at the level of the right atrium and
inferior vena cava proved negative, and we continued the operation
by bypassing the first obtuse marginal and left anterior descending
coronary artery with a saphenous vein graft and the left internal
thoracic artery consecutively. The postoperative course was un-
eventful, and the patient was discharged home in good condition.
Discussion
Although only 40% of patients aged older than 20 years with CAF
are asymptomatic,4 the exact role of CAFs as a nonatherosclerotic
cause of myocardial ischemia has not been fully studied. Stierle
and colleagues,5 using a sinus lactate study, demonstrated the role
of the steal mechanism of CAFs, whereas Bamoshmoosh and
associates2 studied the reverse phenomenon, the redistribution of
blood flow from the fistula to the coronary vessel. This so-called
reverse steal phenomenon might offer an explanation as to how
patients with severe CAD and remarkable shunt resulting from a
CAF can survive so long.
Nevertheless, it still remains difficult to explain how a Qp/Qs
ratio of 1.4 or more resulting exclusively from a big LMCA fistula
is compatible with life, when we all know that the overall coronary
blood flow in rest represents only 4% of systemic circulation.
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